Category Archives: Hypogonadism



Hypogonadism: MedlinePlus Medical Encyclopedia


Posted by Dr. Michael White, Updated on December 17th, 2017

Reading Time: < 1 minuteHypogonadismoccurs when the body's sex glands produce little or no hormones. In men, these glands (gonads) are the testes. In women, these glandsare the ovaries. The cause of hypogonadismis primary or central. In primary hypogonadism, the ovaries or testes themselves do not function properly. Causes of primary hypogonadism include: The most common genetic disorders that cause primary hypogonadism are Turner syndrome (in women) and Klinefelter syndrome (in men). In central hypogonadism, the centers in the brain that control the gonads (hypothalamus and pituitary) do not function properly. Causes of central hypogonadism include: A genetic cause of central hypogonadism that also … Read more »

Hypogonadism – HealthCentral


Posted by Dr. Michael White, Updated on December 14th, 2017

Reading Time: < 1 minuteDefinition Hypogonadism is when the sex glands produce little or no hormones. In men, these glands (gonads) are the testes; in women, they are the ovaries. Gonadal deficiency The cause of hypogonadism may be "primary" or "central." In primary hypogonadism, the ovaries or testes themselves do not function properly. Some causes of primary hypogonadism include: The most common genetic disorders that cause primary hypogonadism are Turner syndrome (in women) and Klinefelter syndrome (in men). In central hypogonadism, the centers in the brain that control the gonads (hypothalamus and pituitary) do not function properly. Some causes of central hypogonadism include: A … Read more »

Hypogonadism – About.com Men’s Health


Posted by Dr. Michael White, Updated on December 12th, 2017

Reading Time: < 1 minuteCauses, signs and symptoms of hypogonadism Hypogonadism is a reduction or absence of hormone secretions from the sex glands (gonads). In men the hormones are secreted from the testes; in women the hormones come from the ovaries. Many types of hypogonadism can be treated and the condition does have a good prognosis. There are two types of hypogonadism; Primary, where the testes fail to function properly, and Central hypogonadism where the centers of the brain responsible for control of the gonads (the hypothalamus and pituitary) do not function properly. Causes of primary and central hypogonadism Primary hypogonadism occurs for a … Read more »

Obese teen boys likelier to become impotent and infertile adults


Posted by Dr. Michael White, Updated on December 11th, 2017

Reading Time: 2 minutesWashington, October 17 (ANI): Obese males ages 14 to 20 have up to 50 percent less total testosterone than do normal males of the same age, significantly increasing their potential to be impotent and infertile as adults. This is according to a study by the University at Buffalo. The researchers are the same ones in the University at Buffalo's School of Medicine and Biomedical Sciences who first reported in 2004 the presence of low testosterone levels, known as hypogonadism, in obese, type 2 diabetic adult males and confirmed it in 2010 in more than 2,000 obese men, both diabetic and … Read more »

Research and Markets: Male Hypogonadism – Pipeline Review, H2 2012


Posted by Dr. Michael White, Updated on December 7th, 2017

Reading Time: < 1 minuteDUBLIN--(BUSINESS WIRE)-- Research and Markets (http://www.researchandmarkets.com/research/3sqllb/male_hypogonadism) has announced the addition of Global Markets Direct's new report "Male Hypogonadism - Pipeline Review, H2 2012" to their offering. Global Markets Direct's, 'Male Hypogonadism - Pipeline Review, H2 2012', provides an overview of the Male Hypogonadism therapeutic pipeline. This report provides information on the therapeutic development for Male Hypogonadism, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Male Hypogonadism. 'Male Hypogonadism - Pipeline Review, H2 2012' is built using data and information sourced from Global Markets Direct's proprietary … Read more »

Hypogonadism: Types, Causes, & Symptoms Healthline


Posted by Dr. Michael White, Updated on December 5th, 2017

Reading Time: < 1 minuteWhat is Hypogonadism? Hypogonadism occurs when your sex glands produce little or no sex hormones. The sex glands, also called gonads, are the testes in men and the ovaries in women. Sex hormones help control sex characteristics, such as breast and testicle development, and pubic hair growth. Sex hormones also play a role in menstrual cycles and sperm production. Hypogonadism may also be called gonad deficiency. In males, it may be called low serum testosterone or andropause. Most cases of this disorder can be successfully treated. 9 Warning Signs of Low Testosterone There are two types of hypogonadism: primary and … Read more »

Trimel Provides Clinical and Operational Update


Posted by Dr. Michael White, Updated on December 2nd, 2017

Reading Time: 2 minutesTORONTO, ONTARIO--(Marketwire - Oct 15, 2012) - Trimel Pharmaceuticals Corporation (TRL.TO) ("the "Company" or "Trimel") today announced progress on three of its product candidates: CompleoTRT Phase III Efficacy Completed The Company announced today that all patients have completed dosing of CompleoTRT for the efficacy portion of the Phase III clinical trial evaluating its lead product in patients with male hypogonadism or more commonly referred to as "Low T".The unique delivery of Compleo TRT is designed to provide hypogonadal men with the therapeutic effect of restoring testosterone levels while doing so with a micro volume amount of drug in the form … Read more »

Signs And Symptoms of Hypogonadism


Posted by Dr. Michael White, Updated on December 29th, 2016

Reading Time: < 1 minuteSigns Symptoms of Hypogonadism Dr. Richard Bebb is a Clinical Assistant Professor of Endocrinology and Metabolism at the University of British Columbia.From:aboutmenshealthViews:717 0ratingsTime:00:40More inPeople Blogs See more here: Signs … Read more »

BioSante Pharmaceuticals, Inc. to Present at BIO Investor Forum


Posted by Dr. Michael White, Updated on October 24th, 2015

Reading Time: < 1 minuteLINCOLNSHIRE, Ill.--(BUSINESS WIRE)-- BioSante Pharmaceuticals, Inc. (BPAX) today announced that Stephen M. Simes, BioSantes president & CEO, will present a corporate update at the 11th Annual BIO Investor Forum hosted by the Biotechnology Industry Organization (BIO). The BIO Investor Forum, which features leading private and emerging public companies, will take place October 9-10, 2012 at the Palace Hotel in San Francisco, CA. The BIO Investor Forum is an international investor conference featuring leading private and emerging public biotech companies. Information about the conference is available at http://www.bio.org/events/conferences/11th-annual-bio-investor-forum. About BioSante Pharmaceuticals, Inc. BioSantes corporate strategy is to develop high value medically-needed … Read more »

Urology Care Foundation – Urology A-Z – Low Testosterone


Posted by Dr. Michael White, Updated on June 19th, 2015

Reading Time: 2 minutesLow serum testosterone, also known as hypogonadism or Andropause, affects roughly 39% of men over the age of 45. The prevalence of low testosterone increases with age. Researcher have found that the incidence of low testosterone increases from approximately 20% of men over 60, to 30% of men over 70 and 50% of men over 80 years of age. What are the signs of low testosterone in men? There are both sexual and non-sexual signs and symptoms associated with low testosterone. Sexual symptoms include poor erectile function, low libido (desire for sex), weaker and fewer erections, and reduced sexual activity. … Read more »

Auxilium Announces Results from Special Meeting of Stockholders


Posted by Dr. Michael White, Updated on May 4th, 2015

Reading Time: 3 minutesCHESTERBROOK, Pa., Jan. 27, 2015 /PRNewswire/ --Auxilium Pharmaceuticals, Inc. (NASDAQ: AUXL), a specialty biopharmaceutical company, announced that it held a special meeting of its stockholders today at 8:30 a.m. ET to approve matters relating to the previously announced proposed merger with Endo International plc. The proposal to adopt the amended and restated agreement and plan of merger was passed by stockholders with approximately 84 percent of outstanding shares voting in favor. Auxilium anticipates that the proposed merger transaction will close on Thursday, January 29, 2015. "As we near the anticipated close of the transaction, I would like to take a … Read more »

Exciting medical advances using HRT


Posted by Dr. Michael White, Updated on May 4th, 2015

Reading Time: 2 minutesby Dr. Angela DeRosa, DeRosa Medical / Special to azfamily.com azfamily.com Posted on December 9, 2013 at 11:26 AM Updated Tuesday, Dec 10 at 3:11 AM PHOENIX -- Good hormonal balance is critical to maintaining good health. When levels of key hormones in the body begin to fall, the door is opened for disease to develop. While levels fall naturally as we age, some medications like antidepressants, oral contraceptives, some beta blockers, steroids and pain killers can cause testosterone levels to plummet. For instance, testosterone drives many metabolic functions, effecting energy levels, glucose metabolism, muscle tone, and of course its … Read more »

HYPOGONADISM – University of Dundee


Posted by Dr. Michael White, Updated on May 4th, 2015

Reading Time: < 1 minuteHYPOGONADISM What is testosterone? Testosterone is the male hormone which is mainly produced by the testis. Small quantities are made in other organs (eg adrenal gland), but in a man this contributes only a small amount of the total. Testosterone is a hormone which is released into the blood which will have effects on other parts of the body. Testosterone is important for: When men have a lack of testosterone the condition is termed hypogonadism What controls the production of testosterone from the testis ? PICTURE A part of the brain called the pituitary release a hormone called lutenising hormone … Read more »

The National Mesothelioma Law Firm of Baron and Budd Reports on a New Drug that Could Improve the Health of …


Posted by Dr. Michael White, Updated on May 4th, 2015

Reading Time: 2 minutesMesothelioma Lawyers raising awareness of new drug that could help improve the health of mesothelioma patients. Dallas, TX (PRWEB) December 17, 2012 "This is another step forward in the medical battle against mesothelioma," said John Langdoc, mesothelioma lawyer at Baron and Budd. "Patients and caregivers need to be aware of these newer developments and we are proud to assist in the awareness process." Currently, mesothelioma doctors typically use a multi-modal approach of surgery, radiation and chemotherapy treatment. The combination of treatments is quite aggressive, and can lead to adverse side affects such as nausea, vomiting, and weight loss. Researchers recently … Read more »

Auxilium Pharmaceuticals, Inc. to Present At The Oppenheimer 23rd Annual Growth Conference


Posted by Dr. Michael White, Updated on May 4th, 2015

Reading Time: 3 minutesMALVERN, Pa., Dec. 7, 2012 /PRNewswire/ --Auxilium Pharmaceuticals, Inc. (AUXL) today announced that executive management will participate in the Oppenheimer Annual Growth Conference to be held December 12-13, 2012 at the Waldorf Astoria Hotel in New York City. Mr. Adrian Adams, Chief Executive Officer and President, is scheduled to present an overview of the Company and its product pipeline at 2:10 p.m. ET on Thursday, December 13, 2012. (Photo: http://photos.prnewswire.com/prnh/20101202/MM10881LOGO) The presentation will also be webcast on the "For Investors" section of the Auxilium website under the "Events" tab on December 13, 2012. The presentation slides to be used will … Read more »

Repros Therapeutics Inc.(R) Reports Third Quarter 2012 Financial Results


Posted by Dr. Michael White, Updated on May 4th, 2015

Reading Time: 3 minutesTHE WOODLANDS, Texas, Nov. 13, 2012 (GLOBE NEWSWIRE) -- Repros Therapeutics Inc.(R) (RPRX) today announced financial results for the third quarter ended September 30, 2012. Liquidity and Capital Resources The Company had cash and cash equivalents of approximately $29.6 million as of September 30, 2012 as compared to $4.6 million as of December 31, 2011. On February 1, 2012, we completed a registered direct offering to certain institutional investors, including certain existing shareholders, of 2,463,537 shares of our common stock at a price per share of $4.50. Net proceeds to us, after deducting placement agent's fees and offering expenses, were … Read more »

Auxilium and Pfizer Will Conclude Agreement on XIAPEX® EU Collaboration


Posted by Dr. Michael White, Updated on May 4th, 2015

Reading Time: 3 minutesMALVERN, Pa. and NEW YORK, Nov. 7, 2012 /PRNewswire/ --Auxilium Pharmaceuticals, Inc. (AUXL), a specialty biopharmaceutical company, and Pfizer Inc. (PFE) are amending their collaboration agreement for the development, commercialization and supply of XIAPEX in the European Union (EU) and certain other European and Eurasian countries (the "Collaboration Agreement"). As a result of this amendment, the Collaboration Agreement will terminate no later than April 24, 2013. Prior to the mutual termination date, the parties will continue to perform all of their obligations as described in the Collaboration Agreement. After the termination date, rights to commercialize XIAPEX and responsibility for regulatory … Read more »

The effect of hypogonadism and testosterone-enhancing therapy – Video


Posted by Dr. Michael White, Published on March 5th, 2015

Reading Time: < 1 minuteThe effect of hypogonadism and testosterone-enhancing therapy on alkaline phosphatase and bone mineral density Read the article: http://onlinelibrary.wiley.com/doi/10.1111/bju.12870/abstract Ali A. Dabaja, Campbell F. B... By: BJUIjournal See the original post here: The effect of hypogonadism and testosterone-enhancing therapy - Video … Read more »

Causes of secondary hypogonadism in males


Posted by Dr. Michael White, Published on March 2nd, 2015

Reading Time: < 1 minuteINTRODUCTION Hypogonadism in a male refers to a decrease in either or both of the two major functions of the testes: sperm production and/or testosterone production (see "Male reproductive physiology"). These abnormalities can result from disease of the testes (primary hypogonadism) or disease of the pituitary or hypothalamus (secondary hypogonadism). The distinction between these disorders is made by measurement of the serum concentrations of luteinizing hormone (LH) and follicle stimulating hormone (FSH): The patient has primary hypogonadism if his serum testosterone concentration and/or sperm count are low and/or his serum LH and FSH concentrations are high. The patient has secondary … Read more »

Testosterone Deficiency (Hypogonadism) Overview …


Posted by Dr. Michael White, Published on November 23rd, 2014

Reading Time: < 1 minuteOverview of Testosterone Deficiency Testosterone production declines naturally with age. Low testosterone, or testosterone deficiency (TD), may result from disease or damage to the hypothalamus, pituitary gland or testicles that inhibits hormone secretion and testosterone production, and is also known as hypogonadism. Depending on age, insufficient testosterone production can lead to abnormalities in muscle and bone development, underdeveloped genitalia and diminished virility. Testosterone is the androgenic hormone primarily responsible for normal growth and development of male sex and reproductive organs, including the penis, testicles, scrotum, prostate and seminal vesicles. It facilitates the development of secondary male sex characteristics such as … Read more »